William Wikoff Smith News Today

Working with researchers from America’s top institutions, Dr. Peter Kowey is senior author of a study assessing treatment for a condition linked to high stroke risk

Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Study results suggest that a novel immunotherapy approach could be developed as a personalized platform to treat various fibrotic diseases or associated disorders.